TWiV 1084: Clinical update with Dr. Daniel Griffin - podcast episode cover

TWiV 1084: Clinical update with Dr. Daniel Griffin

Feb 03, 202444 minEp. 1084
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

In his weekly clinical update, Dr. Griffin discusses the how the pandemic influenced the healthcare job market before he reviews most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus, including all circulating variants in the US, discusses the safety of the prefusion RSV vaccine, if high or moderate dose of the quadrivalent influenza vaccine is better for protection against hospitalization, summarizes the new WHO COVID guidelines, revisits how to prevent pathogen transmission in healthcare setting, the under use of COVID oral antiviral and what occurs in persistently SARS-CoV-2 infected cells in culture after antiviral treatment, continues to dispel the myth of viral rebound, how to pay for paxlovid, when to use steroids and the benefits of convalescent plasma, how inflammatory markers change correlate with death when in ICU and if cognitive slowing is part of long COVID-19.

Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
TWiV 1084: Clinical update with Dr. Daniel Griffin | This Week in Virology podcast - Listen or read transcript on Metacast